Complex Regional Pain Syndrome Market Segments and Forecast By End-us FMI | Page 5
As CRPS can begin at any age including children, 90 % of CRPS occurs if enough care is not taken by an individual after any serious injury such as fractures, soft tissue injury, limb immobilization, sprains and surgical procedures. National Institutes of Health( NIH) is supporting research for CRPS on the brain and CNS by focusing on studying new approaches in treating CRPS.
On the basis of region prevalence, CRPS is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Request for TOC: http:// www. futuremarketinsights. com / toc / rep-gb-1708
As it is one of the rare condition there is limited data available for regional market share for CRPS but there are 50 % chances of multiple sclerosis( MS) patients to develop CRPS and currently North America is one of the leading region in terms of market share followed by Europe and Asia pacific.
Some of the key market players of the complex regional pain syndrome market include Mallinckrodt Pharmaceutical, GlaxoSmithKline plc., Mylan N. V., Teva Pharmaceutical Industries Ltd., AbbVie, ACTAVIS, Zydus Pharmaceuticals, Inc., Sandoz, and Janssen Global Services, LLC..
Report Description
As CRPS can begin at any age including children, 90 % of CRPS occurs if enough care is not taken by an individual after any serious injury such as fractures, soft tissue injury, limb immobilization, sprains and surgical procedures. National Institutes of Health( NIH) is supporting research for CRPS on the brain and CNS by focusing on studying new approaches in treating CRPS.
On the basis of region prevalence, CRPS is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Request for TOC: http:// www. futuremarketinsights. com / toc / rep-gb-1708
As it is one of the rare condition there is limited data available for regional market share for CRPS but there are 50 % chances of multiple sclerosis( MS) patients to develop CRPS and currently North America is one of the leading region in terms of market share followed by Europe and Asia pacific.
Some of the key market players of the complex regional pain syndrome market include Mallinckrodt Pharmaceutical, GlaxoSmithKline plc., Mylan N. V., Teva Pharmaceutical Industries Ltd., AbbVie, ACTAVIS, Zydus Pharmaceuticals, Inc., Sandoz, and Janssen Global Services, LLC..